Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
75 studies found for:    Open Studies | "Sexual Dysfunctions, Psychological"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Sexual Dysfunctions, Psychological"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Conditions: Sexual Dysfunctions, Psychological;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Uterine Neoplasms;   Genital Neoplasms, Female
Intervention: Behavioral: GyneGals Support Group
2 Not yet recruiting Urinary and Sexual Function Before and After Surgical Decompression of Cervical Myelopathy
Conditions: Myelopathy;   Neurogenic Bladder;   Erectile Dysfunction;   Psychosexual Dysfunctions;   Sexual Arousal Disorder
Intervention:
3 Unknown † Testosterone Patch's Effects on the Cardiovascular System and Libido
Condition: Hypoactive Sexual Desire Disorder
Intervention: Drug: Intrinsa Transdermal testosterone patch
4 Unknown † Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder
Condition: Hypoactive Sexual Desire Disorder
Interventions: Drug: Dehydroepiandrosterone;   Drug: placebo
5 Recruiting Stress Hormones, Mood and Women's Sexual Desire (MODEST)
Condition: Hypoactive Sexual Desire Disorder (HSDD).
Intervention:
6 Recruiting A Phase 3 Trial With an Open-label Extension Study
Condition: Hypoactive Sexual Desire Disorder
Intervention: Drug: Bremelanotide
7 Recruiting A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial With an Open-label Extension
Condition: Hypoactive Sexual Desire Disorder
Intervention: Drug: bremelanotide
8 Recruiting Effects of Tribulus Terrestris in Postmenopausal Women With Hypoactive Sexual Desire Disorder
Conditions: Menopause;   Sexual Abstinence
Interventions: Drug: Tribulus Terrestris;   Other: Placebo
9 Unknown † A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies
Condition: Erectile Dysfunction
Interventions: Drug: Sildenafil Citrate 20mg Tablet Sublingual;   Drug: Viagra ® 50mg tablet Coated
10 Recruiting Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy
Condition: Delayed Graft Function
Intervention: Other: adipose derived stem cells
11 Recruiting Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions
Conditions: Neurodegenerative Diseases;   Osteoarthritis;   Erectile Dysfunction;   Autoimmune Diseases;   Cardiomyopathies;   Emphysema
Intervention: Procedure: Administration of autologous adipose derived SVF
12 Unknown † Double Blind Placebo Controlled Study on the Effect of Extracorporal Shock Wave Therapy on Erectile Dysfunction in PDE5i Responders
Condition: Erectile Dysfunction
Intervention: Device: "MEDISPEC" treatment probe
13 Recruiting Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis
Conditions: Cirrhosis;   Erectile Dysfunction
Interventions: Drug: Vardenafil;   Procedure: HVPG (Hepatic venous pressure measurement) baseline;   Procedure: HVPG (Hepatic venous pressure measurement) day 7;   Behavioral: IIEF 5 (International Index of Erectile Function) questionaire baseline;   Behavioral: IIEF 5 (International Index of Erectile Function) questionnaire at study phase end;   Drug: Placebo intake once daily
14 Unknown † Early Start of Oral Sildenafil 100mg for Erectile Dysfunction After Robotic Assisted Laparoscopic Radical Prostatectomy
Condition: Prostate Cancer
Intervention: Drug: sildenafil 100mg
15 Unknown † Evaluation of Safety and Effectiveness of 2 Lower Dose Combined PDE5i's Versus Single Maximal Dose PDE5i Treatment
Condition: Erectile Dysfunction
Interventions: Drug: Sildenafil 100 mg;   Drug: Tadalafil 20 mg;   Drug: Combination half of maximal dose for sildenafil & tadalafil
16 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation
Condition: Premature Ejaculation
Interventions: Drug: DA-8031;   Drug: Placebo
17 Recruiting Erythropoietin to Enhance Erection Recovery in Men Following Radical Prostatectomy
Conditions: Prostate Cancer;   Erectile Dysfunction
Interventions: Drug: Placebo;   Drug: EPO
18 Unknown † Extracorporeal Shock Wave Therapy With a Wide Focus Probe for the Treatment of Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Device: Low intensity shock waves
19 Not yet recruiting Low Frequency Shockwave Therapy for Improving Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Other: Pre-inclusion questionnaires;   Drug: 1 month of PDE5i treatment;   Other: PDE5i follow-up questionnaires;   Other: Inclusion questionnaires;   Device: 4 weekly LIESWT (Wave 1) with the RENOVA device;   Device: 4 weekly sham LIESWT (Wave 1) with the RENOVA device;   Other: Follow-up questionnaires 1 month after Wave 1;   Other: Follow-up questionnaires 3 months after Wave 1;   Device: 4 weekly LIESWT (Wave 2) with the RENOVA device;   Other: Follow-up questionnaires 1 month after Wave 2;   Other: Questionnaires via postal mail;   Other: Final follow-up questionnaires 12 months after Wave 2
20 Recruiting A Safety and Efficacy Study of BOTOX® in Premature Ejaculation
Condition: Premature Ejaculation
Interventions: Drug: OnabotulinumtoxinA;   Drug: Normal Saline
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years